SCHEMBL17023052

SCHEMBL17023052

CN1CCN(Cc2ccc(NC(=O)Oc3ccc(-c4csc5ccccc45)c4nccnc34)nc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 17/20 0.57
PTGER2 P43116 2/20 0.39
F10 P00742 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12678289 0.87 FGFR3 (0.74) FGFR3F10
SCHEMBL17023017 0.87 FGFR3 (0.65) FGFR3
SCHEMBL17023126 0.86 FGFR3 (0.77) FGFR3F10
SCHEMBL17023075 0.85 FGFR3 (0.54) FGFR3F10
SCHEMBL17023144 0.83 FGFR3 (0.58) FGFR3PTGER2
SCHEMBL17023097 0.83 FGFR3 (0.59) FGFR3F10
SCHEMBL17023084 0.79 FGFR3 (0.79) FGFR3
SCHEMBL17023016 0.79 FGFR3 (0.49) FGFR3
SCHEMBL17023100 0.78 FGFR3 (0.80) FGFR3
SCHEMBL17023078 0.78 FGFR3 (0.81) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed